Similar Papers

Paper Title
Journal
Date
Author
What Can We Learn From Clinical Trials of Exon Skipping for DMD?
Qi-Long Lu ... Sebahattin Cirak
Molecular Therapy - Nucleic Acids | VOL. 3
Qi-Long Lu, et. al.Qi-Long Lu ... Sebahattin Cirak
01 Jan 2014
Holter electrocardiogram should be systematic in Duchenne muscular dystrophy
A Fayssoil
International Journal of Cardiology | VOL. 128
A FayssoilA Fayssoil
27 Jul 2007
Efficacy of Multi-exon Skipping Treatment in Duchenne Muscular Dystrophy Dog Model Neonates
Kenji Rowel Q Lim ... Masanori Kobayashi
Molecular Therapy | VOL. 27
Kenji Rowel Q Lim, et. al.Kenji Rowel Q Lim ... Masanori Kobayashi
19 Oct 2018
Behavior patterns in Duchenne muscular dystrophy: Report on the Parent Project Muscular Dystrophy behavior workshop 8–9 of December 2006, Philadelphia, USA
James Poysky
Neuromuscular Disorders | VOL. 17
James PoyskyJames Poysky
27 Aug 2007
View more papers

More From: Neuromuscular Disorders

Paper Title
Journal
Date
Author
CMT2 and distal hereditary motor neuropathy associated with VRK1 variants: case series
Sasha A Živković ... Daniel Dicapua
Neuromuscular Disorders | VOL. 47
Sasha A Živković, et. al.Sasha A Živković ... Daniel Dicapua
01 Feb 2025
Management of presymptomatic juvenile patients with Late-Onset Pompe Disease (LOPD)
M Porcino ... A Toscano
Neuromuscular Disorders | VOL. -
M Porcino, et. al.M Porcino ... A Toscano
01 Jan 2025
MRC CENTRE NEUROMUSCULAR DISEASE BIOBANK LONDON: ITS ROLE IN THE ADVANCEMENT OF RARE AND NEUROMUSCULAR DISEASES RESEARCH
Pierpaolo Ala ... Jennifer Morgan
Neuromuscular Disorders | VOL. -
Pierpaolo Ala, et. al.Pierpaolo Ala ... Jennifer Morgan
01 Jan 2025
Safety and efficacy of tamoxifen in non-ambulant patients with Duchenne muscular dystrophy: a multicentre, randomised, double–blind, placebo–controlled, phase 3 trial (TAMDMD Group B)
Bettina C Henzi ... Dirk Fischer
Neuromuscular Disorders | VOL. -
Bettina C Henzi, et. al.Bettina C Henzi ... Dirk Fischer
01 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.